EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Traws Pharma, Inc. (TRAW) EBITDA Margin data is not available.
| Income Statement Financials | |
-- |
|
$-5.69M |
|
-- |
|
-- |
|
$6.95M |
|
$-6.95M |
|
$-0.16M |
|
$-7.11M |
|
$-7.11M |
|
$-7.11M |
|
$-7.11M |
|
$-7.11M |
|
$-7.11M |
|
$-6.95M |
|
$-6.90M |
|
10.64M |
|
10.64M |
|
$-0.53 |
|
$-0.53 |
|
| Balance Sheet Financials | |
$5.67M |
|
$0.01M |
|
$2.49M |
|
$8.16M |
|
$13.21M |
|
-- |
|
$0.26M |
|
$13.47M |
|
$-5.31M |
|
$-7.79M |
|
$-5.31M |
|
10.16M |
|
| Cash Flow Statement Financials | |
$-2.58M |
|
$0.00M |
|
$1.90M |
|
$3.82M |
|
$3.13M |
|
$-0.69M |
|
$0.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.43 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBITDA Margin |
-- |
-- |
|
-- |
|
$-2.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
133.82% |
|
91.17% |
|
-87.14% |
|
133.82% |
|
$-0.52 |
|
$-0.24 |
|
$-0.24 |
|